SynovX Recovery by XYMOGEN — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size

60 Servings

Non-Nutrient/Non-Botanical Product Type

33% Evidence Coverage

Supplement Facts — Evidence Check

Glucosamine Sulfate

750 mg

📊 Market median: 1000.0mg (1115 products) 📚 22 studies (Tier A: 0, B: 9)

This product: 750mg

CSBioactive

600 mg

Methylsulfonylmethane

475 mg

📊 Market median: 1000.0mg (2 products)

This product: 475mg

Other Ingredients

Hypromellose Water Ascorbyl Palmitate Medium Chain Triglyceride Oil Silica

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (89% of products) Nutrient (16% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

DIRECTIONS: Take two capsules twice daily, or as directed by your healthcare professional.

⚠️ Warnings & Precautions

Consult your healthcare practitioner prior to use.

Individuals taking warfarin or other medication should discuss potential interactions with their healthcare practitioner.

Do not use if tamper seal is damaged.

STORAGE: Keep closed in a cool, dry place out of reach of children.

Contains: Crustacean shellfish (shrimp and crab).

🧪 Formulation Notes

SynovX Recovery features methylsulfonylmethane (MSM) blended with naturally occurring, clinically researched glucosamine sulfate and chondroitin sulfate.

Ultra-pure joint support

Combined, these three ingredients provide targeted support for healthy joint structure and function.

Additional Information

STORAGE: Keep closed in a cool, dry place out of reach of children.

Vegetarian caps

ePV (ePedigree Verification)

GMP compliant third-party verified

Scan to learn more! This package is completely recyclable

Product Details

UPC / SKU 8 71149 00045 5

DSLD Entry Date 2024-01-24

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand XYMOGEN

DSLD ID 303847

Data Updated 2026-04-11

Research Evidence

39 Research Sources

50 Avg Quality Score

20 Rct

9 Meta Analysis

4 Clinical Trial

3 Systematic Review

1 Regulatory Source

1 Openfda Safety

B Interventions for the management of temporomandibular joint osteoarthritis

Systematic Review The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

B Glucosamine therapy for treating osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2005

PubMed Cochrane

B Chondroitin for osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis

Meta Analysis Archives of orthopaedic and trauma surgery 2023

PubMed DOI

B Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

Rct The New England journal of medicine 2006

PubMed

B Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review

Systematic Review International journal of molecular sciences 2023

PubMed DOI

B Scientific Opinion on glucosamine and joint health

Regulatory Source EFSA Journal 2009

DOI

B Clinical Efficacy and Safety of Chondroitin Combined with Glucosamine in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis

Meta Analysis Computational and mathematical methods in medicine 2022

PubMed DOI

B Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Rct Annals of the rheumatic diseases 2016

PubMed DOI

B Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials

Meta Analysis Journal of orthopaedic surgery and research 2018

PubMed DOI

View all evidence for Glucosamine →